Dissociation kinetics of open-chain and macrocyclic gadolinium(III)-aminopolycarboxylate complexes related to magnetic resonance imaging: catalytic effect of endogenous ligands.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Chemistry

• Publication date

  2012-12-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/chem.201202930PMID 23139193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nephrogenic systemic fibrosis is found only among gadolinium‐exposed patients with renal insufficiency: a case–control study from Denmark

  2011cited by this paper
• The role of phosphate on Omniscan® dechelation: an in vitro relaxivity study at pH 7

  2011cited by this paper
• Kinetics of the exchange reactions between Gd(DTPA)2-, Gd(BOPTA)2-, and Gd(DTPA-BMA) complexes, used as MRI contrast agents, and the triethylenetetraamine-hexaacetate ligand.

  2011cited by this paper
• Imaging patients with kidney disease in the era of NSF: can it be done safely?

  2011cited by this paper
• Equilibrium Studies on the Gd3+, Cu2+ and Zn2+ Complexes of BOPTA, DTPA and DTPA‐BMA Ligands: Kinetics of Metal‐Exchange Reactions of [Gd(BOPTA)]2–

  2010cited by this paper
• Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.

  2010cited by this paper
• Current status of gadolinium toxicity in patients with kidney disease.

  2009cited by this paper
• NSF after Gadovist exposure: a case report and hypothesis of NSF development.

  2009cited by this paper
• SIMS imaging of gadolinium isotopes in tissue from Nephrogenic Systemic Fibrosis patients: Release of free Gd from magnetic resonance imaging (MRI) contrast agents

  2008cited by this paper
• Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis.

  2008cited by this paper
• Hair and fingernail gadolinium ICP-MS contents in an overdose case associated with nephrogenic systemic fibrosis.

  2008cited by this paper
• Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C

  2008cited by this paper
• Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis.

  2008cited by this paper
• Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review

  2008cited by this paper
• Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications.

  2007cited by this paper
• Editorial: Gadolinium Use in Patients with Kidney Disease: A Cause for Concern

  2007cited by this paper
• Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?

  2007cited by this paper
• Formation and dissociation kinetics of Eu(III) complexes with H5do3ap and similar dota-like ligands

  2007cited by this paper
• Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis.

  2007cited by this paper
• Case-control study of gadodiamide-related nephrogenic systemic fibrosis.

  2007cited by this paper
• Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition?

  2007cited by this paper
• Nephrogenic systemic fibrosis: risk factors and incidence estimation.

  2007cited by this paper
• Dialyzability of gadodiamide in hemodialysis patients

  2006cited by this paper
• Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

  2006cited by this paper
• Comparison of Gd(DTPA-BMA) (Omniscan) Versus Gd(HP-DO3A) (ProHance) Relative to Gadolinium Retention in Human Bone Tissue by Inductively Coupled Plasma Mass Spectroscopy

  2006cited by this paper
• Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging.

  2006cited by this paper
• Studies on the kinetic stabilities of the Gd(3+) complexes formed with the N-mono(methylamide), N'-mono(methylamide) and N,N"-bis(methylamide) derivatives of diethylenetriamine-N,N,N',N",N"-pentaacetic acid.

  2002cited by this paper
• Dissociation Kinetics of Cerium(lll) Complexes of Macrocyclic Polyaza Polycarboxylate Ligands TETA and DOTA

  2000cited by this paper
• The rates of the exchange reactions between [Gd(DTPA)]2- and the endogenous ions Cu2+ and Zn2+: a kinetic model for the prediction of the in vivo stability of [Gd(DTPA)]2-, used as a contrast agent in magnetic resonance imaging.

  2000cited by this paper
• Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications.

  1999cited by this paper
• Safety of magnetic resonance imaging contrast agents

  1999cited by this paper
• Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis.

  1998cited by this paper
• Structures and Dynamics of Lanthanide(III) Complexes of Sugar-Based DTPA-bis(amides) in Aqueous Solution: A Multinuclear NMR Study

  1997cited by this paper
• Stability constants and 1H relaxation effects of ternary complexes formed between gd‐dtpa, gd‐dtpa‐bma, gd‐dota, and gd‐edta and citrate, phosphate, and carbonate ions

  1997cited by this paper
• Structural and Dynamic Parameters Obtained from 17O NMR, EPR, and NMRD Studies of Monomeric and Dimeric Gd3+ Complexes of Interest in Magnetic Resonance Imaging: An Integrated and Theoretically Self-Consistent Approach1

  1996cited by this paper
• Equilibrium and kinetic studies on complexes of 10-[2,3-dihydroxy-(1-hydroxymethyl)-propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetate

  1996cited by this paper
• Clearance of gadolinium chelates by hemodialysis: An in vitro study

  1995cited by this paper
• Biodistribution of Radiolabeled, Formulated Gadopentetate, Gadoteridol, Gadoterate, and Gadodiamide in Mice and Rats

  1995cited by this paper
• Gd‐DOTA as a gastrointestinal contrast agent for gastric emptying measurements with MRI

  1994cited by this paper
• Kinetics of Formation and Dissociation of Lanthanide(III)-DOTA Complexes

  1994cited by this paper
• Solution Structure and Dynamics of Lanthanide Complexes of the Macrocyclic Polyamino Carboxylate DTPA-dien. NMR Study and Crystal Structures of the Lanthanum(III) and Europium(III) Complexes

  1994cited by this paper
• Gadodiamide injection. First human experience with the nonionic magnetic resonance imaging enhancement agent.

  1993cited by this paper
• Multinuclear magnetic resonance study of the structure and dynamics of lanthanide(III) complexes of the bis(propylamide) of diethylenetriaminepentaacetic acid in aqueous solution

  1993cited by this paper
• The Physiologic Effects of Nonionic Contrast Media on the Heart

  1993cited by this paper
• A kinetic investigation of the lanthanide DOTA chelates. Stability and rates of formation and of dissociation of a macrocyclic gadolinium(III) polyaza polycarboxylic MRI contrast agent

  1992cited by this paper
• Pharmacokinetics of Gd-DTPA in patients with chronic renal failure.

  1991cited by this paper
• Solution structure and dynamics of DTPA-Ln(III) complexes (DTPA=diethylene triamine penta acetate; LnLa, Pr, Eu)

  1990cited by this paper
• Gadolinium (III) complex equilibria: The implications for Gd(III) MRI contrast agents

  1990cited by this paper
• The relationship between thermodynamics and the toxicity of gadolinium complexes.

  1990cited by this paper
• Kinetics of the acid dissociation of oligopeptide complexes of copper(II) and nickel(II): a study on general-acid catalysis with "noncoordinating" 2,6-lutidine type buffers

  1989cited by this paper
• Comparative chemical structure and pharmacokinetics of MRI contrast agents.

  1988cited by this paper
• Solution structure and dynamics of lanthanide(III) complexes of diethylenetriaminepentaacetate: a two-dimensional NMR analysis

  1988cited by this paper
• The Shape of Things To Come

  1988cited by this paper
• Comparative Chemical Structure and Pharmacokinetics of MRI Contrast Agents

  1988cited by this paper
• Multinuclear NMR study of lanthanide(III) complexes of diethylenetriaminepentaacetate

  1988cited by this paper
• PSEQUAD: A Comprehensive Program for the Evaluation of Potentiometric and/or Spectrophotometric Equilibrium Data Using Analytical Derivatives

  1985cited by this paper
• Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.

  1984cited by this paper
• Aminopolycarboxylates of rare earths. X. 1H-NMR spectroscopic study of the mechanism of dissociation of ethylenediamine-N,N,N′,N′-tetraacetate complexes of cerium(III) and yttrium(III)

  1983cited by this paper
• Aminopolycarboxylates of rare earths—VIII: Kinetic study of exchange reactions between Eu3+ ions and lanthanide(III) diethylenetriaminepentaacetate complexes

  1981cited by this paper
• KINETICS OF THE ACID-CATALYZED DISSOCIATION OF NICKEL(II) TRIGLYCINE

  1981cited by this paper
• Computer simulation of metal-ion equilibria in biofluids: models for the low-molecular-weight complex distribution of calcium(II), magnesium(II), manganese(II), iron(III), copper(II), zinc(II), and lead(II) ions in human blood plasma

  1977cited by this paper
• Multidentate Ligand Kinetics. IX. The Effect of Coordinated Anions on the Dissociation Rate of 1,2-Diaminocyclohexanetetraacetatomercurate(II)

  1966cited by this paper
• Observations on the rare earths—LXXV(1)

  1962cited by this paper

• Stereochemistry of rare earth polyaminocarboxylate complexes

  2026cites this paper
• Digadoglucitol: A New High Relaxivity MRI Contrast Agent Based on the Dimerization of [Gd(HP-DO3A)] and Activated Intramolecular Catalysis of the Prototropic Exchange

  2025cites this paper
• Decadentate Acyclic Chelators for Lanthanum Radiopharmaceuticals

  2025cites this paper
• Lanthanide complexes with acetophenone-based push-pull antennas as efficient MRI and two-photon microscopy imaging probes

  2025cites this paper
• Exploring the Coordination Chemistry and Potential Applications of PC3PA-Based Lanthanide Complexes: Synthesis, Solution Structure, Luminescence, and Relaxation Properties.

  2025cites this paper
• Chiral Switch of Gadopiclenol: New Standards in MRI Probes

  2025cites this paper
• Gadolinium in the Environment: A Double-Edged Sword for Plant Growth and Ecosystem Stability

  2025cites this paper
• EHDTA: a green approach to efficient Ln3+-chelators.

  2024cites this paper
• Dynamics of Lanthanide(III) complexes from crystallographic data and computational studies

  2024cites this paper
• The Legacy of AAZTA—Synthesis and Coordination Chemistry of Two AAZTA Structural Analogs

  2024cites this paper
• Investigation of Ln3+ complexation by a DOTA derivative substituted by an imidazothiadiazole: synthesis, solution structure, luminescence and relaxation properties.

  2024cites this paper
• [Gd(HB-DO3A)]: Equilibrium, Dissociation Kinetic and Structural Differences in a Simple Homolog of [Gd(HP-DO3A)] (Prohance®).

  2024cites this paper
• Ultra-inert lanthanide chelates as mass tags for multiplexed bioanalysis

  2024cites this paper
• Prediction of Gd(Iii) Complex Thermodynamic Stability

  2022cites this paper
• The Spreads and the Uniqueness of the Controversial Toxic Pharmaceutic Contrast Agents and Their Remediation.

  2022cites this paper
• Gadolinium based contrast agents (GBCAs): Uniqueness, aquatic toxicity concerns, and prospective remediation.

  2022cites this paper
• A red-emitting Europium(III) complex as a luminescent probe with large Stokes shift for the sequential determination of Cu2+ and biothiols in real samples.

  2022cites this paper
• Rigidified Derivative of the Non-macrocyclic Ligand H4OCTAPA for Stable Lanthanide(III) Complexation

  2022cites this paper
• Lanthanide(III) Complexes Based on an 18-Membered Macrocycle Containing Acetamide Pendants. Structural Characterization and paraCEST Properties

  2021cites this paper
• Speciation analysis of Gadolinium-based contrast agents using aqueous eluent-hydrophilic interaction liquid chromatography hyphenated with inductively coupled plasma-mass spectrometry.

  2021cites this paper
• How the catalysis of the prototropic exchange affects the properties of lanthanide(III) complexes in their applications as MRI contrast agents

  2021cites this paper
• Towards 213Bi alpha-therapeutics and beyond: unravelling the foundations of efficient BiIII complexation by DOTP

  2021cites this paper
• Complexes of Bifunctional DO3A-N-(α-amino)propinate Ligands with Mg(II), Ca(II), Cu(II), Zn(II), and Lanthanide(III) Ions: Thermodynamic Stability, Formation and Dissociation Kinetics, and Solution Dynamic NMR Studies

  2021cites this paper
• Underlining the Importance of Peripheral Protic Functional Groups to Enhance the Proton Exchange of Gd-Based MRI Contrast Agents

  2021cites this paper
• Stability of MRI contrast agents in high-energy radiation of a 1.5 T MR-linac.

  2021cites this paper
• Enhanced relaxivity of GdIII-complexes with HP-DO3A-like ligands upon the activation of the intramolecular catalysis of the prototropic exchange

  2021cites this paper
• Dynamic Contrast Enhancement (DCE) MRI-Derived Renal Perfusion and Filtration: Basic Concepts.

  2021cites this paper
• Acid-catalyzed proton exchange as a novel approach for relaxivity enhancement in Gd-HPDO3A-like complexes†

  2020cites this paper
• Interaction of macrocyclic gadolinium-based MR contrast agents with Type I collagen. Equilibrium and kinetic studies.

  2020cites this paper
• Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles

  2020cites this paper
• Unexpected Trends in the Stability and Dissociation Kinetics of Lanthanide(III) Complexes with Cyclen-Based Ligands across the Lanthanide Series.

  2020cites this paper
• Biomineralized Gd/Dy composite nanoparticles for enhanced tumor photoablation with precise T/T-MR/CT/thermal imaging guidance

  2020cites this paper
• Comparison of the equilibrium, kinetic and water exchange properties of some metal ion-DOTA and DOTA-bis(amide) complexes.

  2020cites this paper
• Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats

  2020cites this paper
• The Use of the Macrocyclic Chelator DOTA in Radiochemical Separations

  2020cites this paper
• Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles

  2020cites this paper
• Complexation of Mn(II) by Rigid Pyclen Diacetates: Equilibrium, Kinetic, Relaxometric, Density Functional Theory, and Superoxide Dismutase Activity Studies.

  2020cites this paper
• Complexation of Mn(II) by Rigid Pyclen Diacetates: Equilibrium, Ki-netic, Relaxometric, DFT and SOD Activity Studies.

  2020cites this paper
• Paramagnetic chemical exchange saturation transfer agents and their perspectives for application in magnetic resonance imaging

  2020cites this paper
• Pyclen-Based Ligands Bearing Pendant Picolinate Arms for Gadolinium Complexation.

  2020cites this paper
• [Gd(AAZTA)]- derivatives with n-alkyl acid side chains show improved properties for their application as MRI contrast agents.

  2020cites this paper
• High field MRI contrast agents and their synergy with optical imaging: the evolution from single molecule probes towards nano-architectures.

  2019cites this paper
• Influence of excess ligand on Nephrogenic Systemic Fibrosis associated with nonionic, linear gadolinium-based contrast agents.

  2019cites this paper
• Modifying LnHPDO3A Chelates for Improved T1 and CEST MRI Applications.

  2019cites this paper
• Carbonate and phosphite encaged in frameworks constructed from square lanthanum aminopolycarboxylates and sodium chloride.

  2019cites this paper
• Controlling water exchange rates in potential Mn2+-based MRI agents derived from NO2A2.

  2019cites this paper
• Measurement of the Dissociation of EuII-Containing Cryptates Using Murexide.

  2019cites this paper
• Nephrogenic Systemic Fibrosis: A Review of History, Pathophysiology, and Current Guidelines

  2019cites this paper
• Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents

  2019cites this paper
• Effect of gadolinium concentration on temperature change under magnetic field

  2019cites this paper
• Gadolinium(III)-Based Dual 1 H/19 F Magnetic Resonance Imaging Probes.

  2019cites this paper
• Gadolinium Complexes of Highly Rigid, Open-Chain Ligands Containing a Cyclobutane Ring in the Backbone: Decreasing Ligand Denticity Might Enhance Kinetic Inertness.

  2019cites this paper
• Magnetic resonance imaging contrast enhancement in vitro and in vivo by octanuclear iron-oxo cluster-based agents.

  2018cites this paper
• Coordination Properties of GdDO3A-Based Model Compounds of Bioresponsive MRI Contrast Agents.

  2018cites this paper
• A Coordination Chemistry Approach to Fine-Tune the Physicochemical Parameters of Lanthanide Complexes Relevant to Medical Applications.

  2018cites this paper
• Relaxivity Enhancement of Ditopic Bishydrated Gadolinium(III) Complexes Conjugated to Mesoporous Silica Nanoparticles

  2018cites this paper
• Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals

  2018cites this paper
• Exploiting the Proton Exchange as an Additional Route to Enhance the Relaxivity of Paramagnetic MRI Contrast Agents.

  2018cites this paper
• Complementarity of molecular and elemental mass spectrometric imaging of Gadovist™ in mouse tissues

  2018cites this paper
• Expanding the Family of Pyclen-Based Ligands Bearing Pendant Picolinate Arms for Lanthanide Complexation.

  2018cites this paper
• Chemical Insights into the Issues of Gd Retention in the Brain and Other Tissues Upon the Administration of Gd-Containing MRI Contrast Agents

  2018cites this paper
• Gd-Based Mesoporous Silica Nanoparticles as MRI Probes

  2018cites this paper
• AAZTA: An Ideal Chelating Agent for the Development of 44 Sc PET Imaging Agents.

  2017cites this paper
• Fragmentation behavior of DOTA complexes under different activation conditions.

  2017cites this paper
• Nano‐sized and other improved reporters for magnetic resonance imaging of angiogenesis☆

  2017cites this paper
• The stability of gadolinium-based contrast agents in human serum: A reanalysis of literature data and association with clinical outcomes.

  2017influential citation
• The Issue of Gadolinium Retained in Tissues: Insights on the Role of Metal Complex Stability by Comparing Metal Uptake in Murine Tissues Upon the Concomitant Administration of Lanthanum- and Gadolinium-Diethylentriamminopentaacetate

  2017cites this paper
• Scleroderma Mimickers

  2016cites this paper
• Gd-AAZTA-MADEC, an improved blood pool agent for DCE-MRI studies on mice on 1 T scanners.

  2016cites this paper
• Gd3TCAS2: An Aquated Gd3+-Thiacalix[4]arene Sandwich Cluster with Extremely Slow Ligand Substitution Kinetics

  2016cites this paper
• A rigidified AAZTA‐like ligand as efficient chelator for 68Ga radiopharmaceuticals

  2016cites this paper
• Gadolinium-Decorated Silica Microspheres as Redox-Responsive MRI Probes for Applications in Cell Therapy Follow-Up.

  2016cites this paper
• Thermal- and pH-Dependent Size Variable Radical Nanoparticles and Its Water Proton Relaxivity for Metal-Free MRI Functional Contrast Agents.

  2016cites this paper
• Cationic gadolinium chelate for magnetic resonance imaging of cartilaginous defects.

  2016cites this paper
• Approaching the Kinetic Inertness of Macrocyclic Gadolinium(III)-Based MRI Contrast Agents with Highly Rigid Open-Chain Derivatives.

  2016cites this paper
• Complexation of Ln(3+) Ions with Cyclam Dipicolinates: A Small Bridge that Makes Huge Differences in Structure, Equilibrium, and Kinetic Properties.

  2016cites this paper
• Physico-chemical properties of MnII complexes formed with cis- and trans-DO2A: thermodynamic, electrochemical and kinetic studies.

  2016cites this paper
• Pyclen Tri-n-butylphosphonate Ester as Potential Chelator for Targeted Radiotherapy: From Yttrium(III) Complexation to (90)Y Radiolabeling.

  2016cites this paper
• High kinetic inertness of a bis-hydrated Gd-complex with a constrained AAZTA-like ligand.

  2016cites this paper
• Analysis of Gadolinium-based contrast agents in tap water with a new hydrophilic interaction chromatography (ZIC-cHILIC) hyphenated with inductively coupled plasma mass spectrometry

  2015cites this paper
• The role of equilibrium and kinetic properties in the dissociation of Gd[DTPA-bis(methylamide)] (Omniscan) at near to physiological conditions.

  2015cites this paper
• Thermodynamic stability, kinetic inertness and relaxometric properties of monoamide derivatives of lanthanide(III) DOTA complexes.

  2015cites this paper
• Equilibrium and dissociation kinetics of the [Al(NOTA)] complex (NOTA = 1,4,7-triazacyclononane-1,4,7-triacetate)

  2015cites this paper
• H4octapa: highly stable complexation of lanthanide(III) ions and copper(II).

  2015cites this paper
• Gd(3+)-Based Magnetic Resonance Imaging Contrast Agent Responsive to Zn(2+).

  2015cites this paper
• Exceptionally Inert Lanthanide(III) PARACEST MRI Contrast Agents Based on an 18-Membered Macrocyclic Platform.

  2015cites this paper
• Basic MR relaxation mechanisms and contrast agent design

  2015cites this paper
• Efficient labeling in vitro with non-ionic gadolinium magnetic resonance imaging contrast agent and fluorescent transfection agent in bone marrow stromal cells of neonatal rats

  2015cites this paper
• NaGdF4 Nanoparticles Coated with Functionalised Ethylenediaminetetraacetic Acid as Versatile Probes for Dual Optical and Magnetic Resonance Imaging.

  2015cites this paper
• [Causal relationship between the use of gadolinium based contrast media and nephrogenic systemic fibrosis].

  2014cites this paper
• Lower denticity leading to higher stability: structural and solution studies of Ln(III)-OBETA complexes.

  2014cites this paper
• Current status of nephrogenic systemic fibrosis.

  2014cites this paper
• Comprehensive evaluation of the physicochemical properties of Ln(III) complexes of aminoethyl-DO3A as pH-responsive T(1) -MRI contrast agents.

  2014cites this paper
• Solution structures, stabilities, kinetics, and dynamics of DO3A and DO3A-sulphonamide complexes.

  2014cites this paper
• Aryl-phosphonate lanthanide complexes and their fluorinated derivatives: investigation of their unusual relaxometric behavior and potential application as dual frequency 1H/19F MRI probes.

  2013cites this paper
• Preparation, crystallographic and theoretical study on a bifunctional Gd-AAZTA derivative as potential MRI contrast agent precursor

  2013cites this paper
• Coupling fast water exchange to slow molecular tumbling in Gd3+ chelates: why faster is not always better.

  2013cites this paper